Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Recruiting 3Terminated 1Active not recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Conditions

Carcinoma, Non-Small-Cell Lung 41Breast Neoplasms 31Neoplasms 28Neoplasm Metastasis 23Melanoma 20Leukemia, Myeloid, Acute 20Prostatic Neoplasms 19Colorectal Neoplasms 17Multiple Myeloma 16Lung Neoplasms 16Recurrence 13Myelodysplastic Syndromes 13Squamous Cell Carcinoma of Head and Neck 12Lymphoma, Non-Hodgkin 12Carcinoma, Renal Cell 12Ovarian Neoplasms 11Lymphoma, Large B-Cell, Diffuse 11Carcinoma, Hepatocellular 11Urinary Bladder Neoplasms 10Uterine Cervical Neoplasms 9Pancreatic Neoplasms 9Glioblastoma 9Head and Neck Neoplasms 8Stomach Neoplasms 7Rectal Neoplasms 7Lymphoma, Follicular 7Glioma 7Brain Neoplasms 7Solid Tumor 6Precursor Cell Lymphoblastic Leukemia-Lymphoma 6

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Terminated × Pathologic Processes × 90 days × Clear all
NCT03694015 2026-03-11

SUPR-3D: Simple Unplanned Palliative Radiotherapy Versus 3D Conformal Radiotherapy for Patients With Bone Metastases

British Columbia Cancer Agency

Phase NA Terminated
160 enrolled

Neoplasm Metastasis, Neoplasms, Neoplastic Processes, Pathologic Processes

Data powered by HemOnc (CC BY 4.0) Colophon âš¡